Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodentine and Hyaluronic Acid for Pulpotomy in Primary Molars
NCT05937100Active, not recruiting
- Sponsor
- Mansoura University
- Start
- May 2023
- Primary completion
- Jul 2025
- Modality
- Hydrogel Systems, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of Biodentine and hyaluronic acid sodium composite gel for injection in dental pulp exposure (3 arms), sponsored by Mansoura University. Primary endpoints: Clinically successful pulpotomy at 18 months and Radiographically successful pulpotomy at 18 months. Started May 2023; status: active, not recruiting.
02
Drugs
Biodentinehyaluronic acid sodium composite gel for injection
03
Conditions
dental pulp exposure
Beyond the preview
Go deeper on NCT05937100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937100.